These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


268 related items for PubMed ID: 20006163

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series.
    Ferlito S, Liardo C, Puzzo S.
    Minerva Stomatol; 2010; 59(11-12):593-601. PubMed ID: 21217623
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER, Basile JD.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [Abstract] [Full Text] [Related]

  • 6. Guidelines for treating patients taking bisphosphonates prior to dental extractions.
    Rogers S, Rahman N, Ryan D, Flint S, Healy C, Stassen LF.
    J Ir Dent Assoc; 2010 May; 56(1):40. PubMed ID: 20337145
    [No Abstract] [Full Text] [Related]

  • 7. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R, Need A, Hughes T, Goss A.
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [Abstract] [Full Text] [Related]

  • 8. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [Abstract] [Full Text] [Related]

  • 9. Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center.
    Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayianni A, Kyrtsonis MC, Repousis P, Barbounis V, Migliorati CA.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):195-202. PubMed ID: 21622014
    [Abstract] [Full Text] [Related]

  • 10. Preventive protocol for tooth extractions in patients treated with zoledronate: a case series.
    Ferlito S, Puzzo S, Liardo C.
    J Oral Maxillofac Surg; 2011 Jun; 69(6):e1-4. PubMed ID: 21316136
    [Abstract] [Full Text] [Related]

  • 11. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
    Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J.
    J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
    [Abstract] [Full Text] [Related]

  • 12. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
    Dodson TB.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
    [Abstract] [Full Text] [Related]

  • 13. Atraumatic extraction of a non-vital tooth in a patient receiving long-term oral bisphosphonates.
    Xiong M, Pearson A, Sabino M, Svoboda L, Ehlis E.
    Northwest Dent; 2010 May; 89(4):27-33. PubMed ID: 20860270
    [No Abstract] [Full Text] [Related]

  • 14. Tooth extraction: Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates?
    Altundag K, Bulut N, Tezcan E, Ozen M, Purnak T.
    J Oral Maxillofac Surg; 2007 Jan; 65(1):154. PubMed ID: 17174785
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical investigation of bisphosphonate-related osteonecrosis of the jaws].
    Dehari H, Tomihara K, Ueda M, Shimanishi M, Ono M, Sasaki T, Igarashi T, Shiratori K, Abe M, Ogi K, Nakamori K, Miyazaki A, Nagai I, Hiratsuka H.
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2587-92. PubMed ID: 20009460
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis.
    Manfredi M, Merigo E, Guidotti R, Meleti M, Vescovi P.
    Int J Oral Maxillofac Surg; 2011 Mar; 40(3):277-84. PubMed ID: 21163625
    [Abstract] [Full Text] [Related]

  • 17. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT, Chiang WF, Chuang CY, Chang SW.
    J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.